Cardiac complications associated with the influenza viruses A subtype H7N9 or pandemic H1N1 in critically ill patients under intensive care

Brazilian Journal of Infectious Diseases

Volumn 21, Issue 1, 2017, Pages 12-18

  Wang, Jiajia ^a   Xu, Hua ^a   Yang, Xinjing ^a   Zhao, Daguo ^a   Liu, Shenglan ^a   Sun, Xue ^a   Huang, Jian an ^a   Guo, Qiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Cardiac complications; H1N1; H7N9

Indexed keywords

BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; CREATINE KINASE MB; OSELTAMIVIR; TROPONIN I; BIOLOGICAL MARKER;

2009 H1N1 INFLUENZA; ADULT; ANTIVIRAL THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HOSPITAL PATIENT; HUMAN; INFLUENZA A VIRUS (H7N9); INTENSIVE CARE; MALE; MIDDLE AGED; PERICARDIAL EFFUSION; PUBLIC HEALTH SERVICE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINUS TACHYCARDIA; ST SEGMENT DEPRESSION; SYSTOLIC DYSFUNCTION; TRICUSPID VALVE REGURGITATION; AGED; ARTIFICIAL VENTILATION; BLOOD; COMPLICATION; CRITICAL ILLNESS; HEART DISEASE; HOSPITAL ADMISSION; INFLUENZA; INFLUENZA A VIRUS (H1N1); INTENSIVE CARE UNIT; MORTALITY; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; TIME FACTOR; VIROLOGY;

ADULT; AGED; BIOMARKERS; CRITICAL ILLNESS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PATIENT ADMISSION; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 85008164735     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2016.10.005     Document Type: Article

References (30)

1. 1 Gao, G.F., Influenza and the live poultry trade. Science, 344, 2014, 235.
2. 2 Gao, H.N., Lu, H.Z., Cao, B., et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 368 (2013), 2277–2285.
3. 3 Mamas, M.A., Fraser, D., Neyses, L., Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol 130 (2008), 304–309.
4. 4 Estabragh, Z.R., Mamas, M.A., The cardiovascular manifestations of influenza: a systematic review. Int J Cardiol 167 (2013), 2397–2403.
5. 5 Karjalainen, J., Nieminen, M.S., Heikkila, J., Influenza A1 myocarditis in conscripts. Acta Med Scand 207 (1980), 27–30.
6. 6 Verel, D., Warrack, A.J., Potter, C.W., Ward, C., Rickards, D.F., Observations on the A2 England influenza epidemic: a clinic pathological study. Am Heart J 92 (1976), 290–296.
7. 7 Greaves, K., Oxford, J.S., Price, C.P., Clarke, G.H., Crake, T., The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection. Arch Intern Med 163 (2003), 165–168.
8. 8 Jang, J.Y., Chang, H.J., Jang, Y., et al. Constrictive pericarditis accompanied by swine-origin influenza A (H1N1) infection. Korean Circ J 40 (2010), 539–542.
9. 9 Cabral, M., Brito, M.J., Conde, M., Oliveira, M., Ferreira, G.C., Fulminant myocarditis associated with pandemic H1N1 influenza A virus. Rev Port Cardiol 31 (2012), 517–520.
10. 10 Davoudi, A.R., Maleki, A.R., Beykmohammadi, A.R., Tayebi, A., Fulminant myopericarditis in an immunocompetent adult due to pandemic 2009 (H1N1) influenza A virus infection. Scand J Infect Dis 44 (2012), 470–472.
11. 11 Adedayo, O., Iheonunekwu, N., Jefferson, D., Acute fulminant myocarditis and the 2009 pandemic influenza A virus (H1N1). West Indian Med J 60 (2011), 217–219.
12. 12 Pugin, J., Auckenthaler, R., Mili, N., Janssens, J.P., Lew, P.D., Suter, P., Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis 43 (1991), 1121–1129.
13. 13 Charles, P.G., Wolfe, R., Whitby, M., et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 47 (2008), 375–384.
14. 14 Knaus, W.A., Draper, E.A., Wagner, D.P., Zimmerman, J.E., APACHE II: a severity of disease classification system. Crit Care Med 13 (1985), 818–829.
15. 15 Vincent, J.L., De Mendonca, A., Cantraine, F., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care unit: results of a multicenter, prospective study. Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Crit Care Med 26 (1998), 1793–1800.
16. 16 Ammann, P., Pfisterer, M., Fehr, T., Rickli, H., Raised cardiac troponins. BMJ 328 (2004), 1028–1029.
17. 17 Sun, R.R., Lu, L., Liu, M., et al. Biomarkers and heart disease. Eur Rev Med Pharmacol Sci 18 (2014), 2927–2935.
18. 18 Brown, S.M., Pittman, J., Miller Iii, R.R., et al. Right and left heart failure in severe H1N1 influenza A infection. Eur Respir J 37 (2011), 112–118.
19. 19 Tomashefski, J.F. Jr., Davies, P., Boggis, C., Greene, R., Zapol, W.M., Reid, L.M., The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol 112 (1983), 112–126.
20. 20 Mercat, A., Richard, J.C., Vielle, B., et al. Positive end-expiratory setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299 (2008), 646–655.
21. 21 Liu, S., Sun, J., Cai, J., et al. Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China. J Infect 67 (2013), 595–605.
22. 22 Shi, J., Xie, J., He, Z., et al. A detailed epidemiological and clinical description of 6 human cases of avian-origin influenza A (H7N9) virus infection in Shanghai. PLoS ONE, 8, 2013, e77651.
23. 23 Chacko, B., Peter, J.V., Pichamuthu, K., et al. Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care. J Crit Care 27 (2012), 106.e1–106.e6.
24. 24 Miller, R.R. 3rd, Markewitz, B.A., Rolfs, R.T., et al. Clinical findings and demographicfactors associated with ICU admission in Utah due to novel 2009 influenza A (H1N1) infection. Chest 137 (2010), 752–758.
25. 25 Erden, I., Erden, E.C., Ozhan, H., et al. Echocardiographic manifestations of pandemic 2009 (H1N1) influenza a virus infection. J Infect 61 (2010), 60–65.
26. 26 Puzelli, S., Buonaguro, F.M., Facchini, M., et al. Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus. J Clin Microbiol 48 (2010), 2298–2300.
27. 27 Zaky, A., Deem, S., Bendjelid, K., Treggiari, M.M., Characterization of cardiac dysfunction in sepsis: an ongoing challenge. Shock 41 (2014), 12–24.
28. 28 Pulido, J.N., Afessa, B., Masaki, M., et al. Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock. Mayo Clin Proc 87 (2012), 620–628.
29. 29 Onitsuka, H., Imamura, T., Miyamoto, N., et al. Clinical manifestations of influenza A myocarditis during the influenza epidemic of winter 1998–1999. J Cardiol 37 (2001), 315–323.
30. 30 Gurevich, V.S., Influenza, autoimmunity and atherogenesis. Autoimmun Rev 4 (2005), 101–105.